Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
Altered intestinal O-glycan expression has been observed in patients with ulcerative colitis and colorectal cancer, but the role of this alteration in the etiology of these diseases is unknown. O-glycans in mucin core proteins are the predominant components of the intestinal mucus, which comprises part of the intestinal mucosal barrier. Core 3–derived O-glycans, which are one of the major types of O-glycans, are primarily expressed in the colon. To investigate the biological function of core 3–derived O-glycans, we engineered mice lacking core 3 β1,3-N-acetylglucosaminyltransferase (C3GnT), an enzyme predicted to be important in the synthesis of core 3–derived O-glycans. Disruption of the C3GnT gene eliminated core 3–derived O-glycans. C3GnT-deficient mice displayed a discrete, colon-specific reduction in Muc2 protein and increased permeability of the intestinal barrier. Moreover, these mice were highly susceptible to experimental triggers of colitis and colorectal adenocarcinoma. These data reveal a requirement for core 3–derived O-glycans in resistance to colonic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The importance of sufficiently complex mucin glycans was demonstrated in studies of mice with truncated glycans as found in O-glycan core 1 or core 3 deficient mice 19, 28.”
From The composition of the gut microbiota shapes the colon mucus barrier (2015) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Self-citationNadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,938
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542 · cited 1×
“This distinguishes C3GnT−/− mice from models of TH1 or TH17 colitis (42, 49, 50).”
BackgroundLinking Colorectal Cancer to Wnt Signaling
Bienz, M., & Clevers, H. (2000) · Cell · doi:10.1016/s0092-8674(00)00122-7 · Cited by 1,515 · cited 2×
“The altered expression of β-catenin/TCF-4, c-myc, and cyclin D1 observed during carcinogenesis in C3GnT−/− mice relates its molecular pathogenesis to that commonly observed in human colorectal cancer (35).”
BackgroundThe Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304 · cited 3×
“The relatively modest immune infl ammatory components in Muc2−/− and C3GnT−/− mice suggest that defi ciencies in mucus layer integrity alone are insuffi cient to drive immune colitis, without the contribution of additional traits aff ecting innate immune function or immunoregulation (42).”
BackgroundImmunity, Inflammation, and Allergy in the Gut
MacDonald, T. T., & Monteleone, G. (2005) · Science · doi:10.1126/science.1106442 · Cited by 1,035 · cited 1×
“Products of these and other immune cell types can induce abnormal epithelial cell growth and survival that contribute to carcinogenesis (9, 52).”
BackgroundColorectal Cancer in Mice Genetically Deficient in the Mucin Muc2
Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. (2002) · Science · doi:10.1126/science.1069094 · Cited by 936 · cited 8×
“In another experiment, PAS (Sigma-Aldrich) and Alcian blue (Newcomer Supply) were used to stain general intestinal carbohydrate moieties.”
BackgroundMethodInfluentialFuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797 · cited 1×
“This distinguishes C3GnT−/− mice from models of TH1 or TH17 colitis (42, 49, 50).”
Background
Cited by
Items 201–300 of 351
Guzmán‐Aránguez, A., Woodward, A. M., Pintor, J. J., & Argüeso, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036628 · Cited by 24
“Mucin carbohydrates are central to the mucosal barrier, and their abrogation has been associated with increased mucosal permeability [16,17,18].”
BackgroundInflammation Controls Sensitivity of Human and Mouse Intestinal Epithelial Cells to Galectin-1
Muglia, C. I., Gobbi, R. P., Smaldini, P., Delgado, M. L. O., Candia, M., Zanuzzi, C. N., Sambuelli, A. M., Rocca, A., Toscano, M. A., Rabinovich, G. A., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25249 · Cited by 25
Microbes, intestinal inflammation and probiotics
Khan, M. W., Kale, A. A., Bere, P., Vajjala, S., Gounaris, E. G., & Pakanati, K. C. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.94 · Cited by 26
RETRACTED ARTICLE: Mouse models of intestinal inflammation and cancer
Westbrook, A. M., Szakmary, A., & Schiestl, R. H. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1747-2 · Cited by 25
“…cancer development is, therefore, much faster in this scheme of treatment compared to many cycles of DSS treatment alone, and it is useful to study the role of inflammation in the promotion of carcinogenesis after initiation (Tanaka 2003; Suzuki et al. 2007; Colussi et al. 2001; Kohno 2005).”
InfluentialRetractedIntestinal mucin-type O -glycans: the major players in the host-bacteria-rotavirus interactions
Raev, S. A., Amimo, J. O., Saif, L. J., & Vlasova, A. N. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2197833 · Cited by 27
“Glycosyltransferases (GTs) provide a critical role in formation of this mucin-type O-glycan biodiversity, while inhibition of these enzymes’ activity results in increased mucus permeability.(45) The expression of secreted ABO(H) antigens and the Lewis b (Le b) antigen is regulated by fucosyltransferase 2 (FUT2), encod…”
BackgroundConditional Gene Targeting in Mouse High Endothelial Venules
Kawashima, H., Hirakawa, J., Tobisawa, Y., Fukuda, M., & Saga, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802327 · Cited by 22
“However, it is of note that mice lacking core 3 O-glycans show increased susceptibility to colitis (41) and that GlcNAc6ST-2 can act on a synthetic core 3 oligosaccharide (39, 40), suggesting a possible role for GlcNAc6ST-2 in the sulfation of colonic mucins that might have anti-inflammatory roles.”
BackgroundAhmed, I., Roy, B. C., Chandrakesan, P., Venugopal, A., Xia, L., Jensen, R. A., Anant, S., & Umar, S. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00372.2012 · Cited by 23
Self-citationAl-Saedi, F., Vaz, D. P., Stones, D. H., & Krachler, A. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.817908 · Cited by 23
Sahasrabudhe, N. M., Lenos, K., van der Horst, J. C., Rodríguez, E., & van Vliet, S. J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0120 · Cited by 23
Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival
Lu, S., Catalano, C., Huhn, S., Pardini, B., Partu, L., Vymetalkova, V. P., Vodičková, L., Levý, M., Büchler, T., Hemminki, K., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216666 · Cited by 21
Abo, H., Muraki, A., Harusato, A., Imura, T., Suzuki, M., Takahashi, K., Denning, T. L., & Kawashima, H. (2023) · JCI Insight · doi:10.1172/jci.insight.165944 · Cited by 24
“Additionally, Muc2 is highly glycosylated, with O-linked glycans attached to serine or threonine residues having protective roles against intestinal inflammation and tumorigenesis (8-10).”
Colon mucus in colorectal neoplasia and beyond
Loktionov, A. S. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i32.4475 · Cited by 21
Deciphering Protein O-GalNAcylation: Method Development and Disease Implication
Yue, S., Wang, X., Ge, W., Li, J., Yang, C., Zhou, Z., Zhang, P., Yang, X., Xiao, W., & Yang, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c01653 · Cited by 21
Garcia, N. V., Hong, K. U., & Matoba, N. (2023) · Biomedicines · doi:10.3390/biomedicines11072066 · Cited by 19
“A similar phenotype is observed in mice lacking the protein complexes required for post-translational processing of MUC2, such as glycosylation [95], sulfonation [96], disulfide bond formation [97], and lipidation/palmitoylation [98].”
BackgroundAn etanercept O-glycovariant with enhanced potency
Biel, T. G., Faison, T., Matthews, A. M., Zou, G., Ortega‐Rodriguez, U., Pegues, M. A., Azer, N., Gomez, F. D., Johnson, S., Rogstad, S., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.03.002 · Cited by 22
Self-citationRole of mucin glycosylation in the gut microbiota-brain axis of core 3 O-glycan deficient mice
Coletto, E., Savva, G. M., Latousakis, D., Pontifex, M. G., Crost, E. H., Vaux, L., Telatin, A., Bergstrom, K., Vauzour, D., & Juge, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-40497-8 · Cited by 21
“Previous analyses showed an increase in total bacteria in mucus as compared to faecal samples in C3GnT −/− mice and C1galt1 −/− mice (core 1 deficient mice) 26 .”
BackgroundResultCore 2 mucin-type O-glycan inhibits EPEC or EHEC O157:H7 invasion into HT-29 epithelial cells
Ye, J., Pan, Q., Shang, Y., Wei, X., Peng, Z., Chen, W., Chen, L., & Wang, R. (2015) · Gut Pathogens · doi:10.1186/s13099-015-0078-9 · Cited by 20
“coli [33], and loss of core 1-, core 2- or core 3-derived O-glycans in animal models caused spontaneous colitis in mice [4, 34].”
BackgroundSong, R., McAlpine, W., Fond, A. M., Nair‐Gill, E., Choi, J. H., Nyström, E. E. L., Arike, L., Field, S., Li, X., SoRelle, J. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39398-1 · Cited by 19
Cancer snap-shots: Biochemistry and glycopathology of O-glycans: A review
Sanji, A. S., Manasa, J., Gurav, M. J., Batra, S. K., & Chachadi, V. B. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129318 · Cited by 18
Gut permeability among Astronauts during Space missions
Akinsuyi, O., Xhumari, J., Ojeda, A. E., & Roesch, L. F. W. (2024) · Life Sciences in Space Research · doi:10.1016/j.lssr.2024.03.003 · Cited by 23
Emergent Behavior of IBD-AssociatedEscherichia coliDuring Disease
Renouf, M. J. D., Cho, Y. H., & McPhee, J. B. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy312 · Cited by 18
Amplification and Preparation of Cellular O-Glycomes for Functional Glycomics
Li, Z., Zhang, Q., Ashline, D. J., Zhu, Y., Lasanajak, Y., Chernova, T. A., Reinhold, V. N., Cummings, R. D., Wang, P. G., Ju, T., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00632 · Cited by 17
Self-citationPeluso, G., Tian, E., Abusleme, L., Munemasa, T., Mukaibo, T., & Hagen, K. G. T. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49899-1 · Cited by 20
Gao, Y. H., Aryal, R. P., Ju, T., Cummings, R. D., Gahlay, G. K., Jarvis, D. L., Matta, K. L., Vlahakis, J. Z., Szarek, W. A., & Brockhausen, I. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.001 · Cited by 19
“C3GnT gene knockout mice further showed that core 3 glycans have a protective function in normal gastro-intestinal epithelia [21].”
BackgroundSelf-citationRondini, E. A., & Bennink, M. R. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/351796 · Cited by 19
Palrasu, M., Marudamuthu, A. S., Kakar, K., Hamida, H., Thada, S., Gupta, R., Wilson, K. M., Carter, T., Yin, Z., Saxena, A., et al. (2025) · Advanced Science · doi:10.1002/advs.202416324 · Cited by 21
MUC17 is an essential small intestinal glycocalyx component that is disrupted in Crohn’s disease
Layunta, E., Jäverfelt, S., van de Koolwijk, F. C., Sivertsson, M., Dolan, B., Arike, L., Thulin, S., Vallance, B. A., & Pelaseyed, T. (2024) · JCI Insight · doi:10.1172/jci.insight.181481 · Cited by 20
“Accordingly, DSS-induced colitis is rapid and severe in mouse models with mucus defects (23–25).”
Vanhooren, V., Vandenbroucke, R. E., Dewaele, S., Hamme, E. V., Haigh, J. J., Hochepied, T., & Libert, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079883 · Cited by 17
“Mice lacking core-3- and core-2-derived O-glycans are more susceptible to colitis [22,23].”
BackgroundHayakawa, S., Matsushita, T., Yokoi, Y., Wakui, H., García‐Martin, F., Hinou, H., Matsuoka, K., Nouso, K., Kamiyama, T., Taketomi, A., et al. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00007 · Cited by 17
Stone, E. L., Lee, S. H., Ismail, M. N., & Fukuda, M. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)79009-1 · Cited by 17
Xia, B., Zhong, R., Meng, Q., Wu, W., Chen, L., Zhao, X., & Zhang, H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.173 · Cited by 16
Self-citationZmudzinska, A., Wiśniewski, J. Ł., Młynarz, P., Olejnik, B., & Mogielnicka-Brzozowska, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169143 · Cited by 17
“Mucin-type O-glycan biosynthesis was intensified in the spermatozoa of obese rats [90].”
BackgroundBiosynthesis of Complex Mucin-Type O-Glycans
Brockhausen, I. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00643-2 · Cited by 20
Common flora and intestine: A carcinogenic marriage
Wang, K., & Karin, M. (2013) · Cellular Logistics · doi:10.4161/cl.24975 · Cited by 17
“Mice lacking the enzyme for mucin glycosylation also showed increased colonic permeability, and are highly susceptible to induction of colitis and CAC.(18) These data indicate that the mucus layer protects the host from colitis and CAC by keeping commensal microflora at a distance from the intestinal epithelium.”
BackgroundUpdate on the role of C1GALT1 in cancer (Review)
Xia, T., Xiang, T., & Xie, H. (2022) · Oncology Letters · doi:10.3892/ol.2022.13217 · Cited by 15
The immune interactions of gut glycans and microbiota in health and disease
(2024) · doi:10.1111/mmi.15267 · Cited by 14
“Alterations in the hGM can contribute to the develop - ment of IBDs (Figure 1b) (Shanahan, 2012).”
InfluentialDasgupta, S., & Kasper, D. L. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06003-7 · Cited by 15
Leite-Gomes, E., Dias, A. M., Azevedo, C. M., Santos‐Pereira, B., Magalhães, M., Garrido, M., Amorim, R., Lago, P. M., Marcos‐Pinto, R., & Pinho, S. S. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab291 · Cited by 15
Das Tn‐Antigen – strukturell einfach und biologisch komplex
Ju, T., Otto, V. I., & Cummings, R. D. (2011) · Angewandte Chemie · doi:10.1002/ange.201002313 · Cited by 14
Self-citationLncRNAEPRregulates intestinal mucus production and protects against inflammation and tumorigenesis
Briata, P., Mastracci, L., Zapparoli, E., Caputo, L., Ferracci, E., Silvestri, A., Garuti, A., Hamadou, M. H., Inga, A., Marcaccini, E., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad257 · Cited by 15
“Previous studies have demonstrated that two major types of O-glycans, named core 1 and core 3 Oglycans, collectively contribute to mucus layer integrity, thus preventing the unrestricted access of bacteria to the mucosa that would lead to spontaneous chronic inflammation (16,40,29).”
BackgroundMethodPeluso, G., Tian, E., Abusleme, L., Munemasa, T., Mukaibo, T., & Hagen, K. G. T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009807 · Cited by 16
Tran, E. N. H., Day, C. J., McCartney, E. M., Poole, J., Tse, E., Jennings, M. P., & Morona, R. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00178 · Cited by 13
Suzuki, R., Nakamura, Y., Koiwai, R., Fuseya, S., Murakami, Y., Hagiwara, K., Sato, T., Takahashi, S., & Kudo, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031273 · Cited by 12
“The deficiency of C1galt1, B3gnt6, or both in intestinal epithelial cells disrupts the colorectal environment and causes spontaneous colitis and tumorigenesis [22,24,26].”
BackgroundRathan-Kumar, S., Roland, J. T., Momoh, M., Goldstein, A. E., Lapierre, L. A., Manning, E., Mitchell, L. E., Norman, J. C., Kaji, I., & Goldenring, J. R. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00042.2022 · Cited by 11
The link between gut microbiota and multiple sclerosis from the perspective of barrier function
Ren, J., Niu, Z., Wang, J., Guo, J., Hao, H.-J., Gao, F., Liu, R., & Wang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652796 · Cited by 15
Bressler, K. R., Ross, J. A., Ilnytskyy, S., Dungen, K. V., Taylor, K., Patel, K., Zovoilis, A., Kovalchuk, I., & Thakor, N. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01174-1 · Cited by 14
“Genetic ablation of various GALNTs in mice has caused defective angiogenesis, fatal brain hemorrhages, and additional consequences (An et al. 2007; Stone et al. 2009; Xia et al. 2004).”
BackgroundShan, X., Rathore, S., Kniffen, D., Gao, L., Nitin, N., Letef, C. A., Shi, H., Ghosh, S., Zandberg, W. F., Xia, L., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101378 · Cited by 11
Self-citationCull, J., Pink, R. C., Samuel, P., & Brooks, S. A. (2025) · Glycobiology · doi:10.1093/glycob/cwaf023 · Cited by 18
Zhang, X., Wang, C., Qing, H., Chen, X., Li, G., & Yu, G. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10014-y · Cited by 14
Xu, L., Li, X., Han, S., Mu, C., & Zhu, W. (2024) · Food & Function · doi:10.1039/d4fo04626a · Cited by 13
Cross-kingdom-mediated detection of intestinal protozoa through NLRP6
Winsor, N. J., Bayer, G., Singh, O., Chan, J. K., Li, L. Y., Lieng, B. Y., Foerster, E. G., Popovic, A., Tsankov, B. K., Maughan, H., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.02.008 · Cited by 11
Wu, H., Zhong, W., Zhang, R., Ding, Y., Sun, B., Qu, C., Lai, K., Pang, Z., Yin, S., Sun, T., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.5721 · Cited by 10
Tsai, K., Ma, C., Han, X., Allaire, J. M., Lunken, G., Crowley, S. M., Yu, H., Jacobson, K., Xia, L., Priatel, J. J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.004 · Cited by 12
Self-citationStarch-enriched diet modulates the glucidic profile in the rat colonic mucosa
Gabrielli, M. G., & Tomassoni, D. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1393-3 · Cited by 10
Functional Assays for the Molecular Chaperone Cosmc
Ju, T., & Cummings, R. D. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)79006-6 · Cited by 9
“In the gastrointestinal tract, there is another coexisting pathway for synthesizing core 3 (An et al., 2007; Iwai et al., 2002, 2005) and core 4 O-glycans by sequential action of specific N-acetylglucosaminyltransferases.”
BackgroundSelf-citationMortensen, J. S., Bohr, S. S.-R., Krog, L. S., Boetker, J. P., Kapousidou, V., Saaby, L., Hatzakis, N. S., Nielsen, H. M., Nguyen, D. N., & Rønholt, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-58356-5 · Cited by 9
“…charged PTMs. Alterations in the PTMs of mucin are known to be crucial for the overall barrier properties of mucus, as the specific PTM structures of MUC2 were found to be essential contributors to the mucus’ ability to trap bacteria and prevent the onset of inflammatory bowel disease 22,23,47–49 .”
BackgroundPetit, C., Rozières, A., Boschetti, G., Viret, C., Faure, M., Nancey, S., & Duclaux‐Loras, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136133 · Cited by 8
“Mice lacking O-glycan synthesis develop spontaneous colitis, with decreased MUC2 expression and increased intestinal permeability [34].”
Tumor-associated Tn and STn antigens: from molecular mechanism to precision diagnosis and treatment
Zhao, S., Fu, C., Gong, B., Wu, H., Zhang, R., Cai, H., & Chen, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1660852 · Cited by 11
Zhao, H.-W., Sun, L., Xiao, X., Lin, J., Shao, C., & Lin, L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3762591 · Cited by 8
“Histological scoring was calculated by adding the six evaluations as follows [21, 22]:”
MethodHu, W., Ding, R., Wang, M., Huang, P., Xia, W., Hu, X., & Hu, T. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03334-3 · Cited by 8
“Beyond that, increased susceptibility to colitis and colorectal tumors in mice lacks core 3-derived O-glycans [57].”
BackgroundFuell, C., Coleman, O. I., Hautefort, I., & Juge, N. (2014) · Glycobiology · doi:10.1093/glycob/cwu088 · Cited by 7
“2011) whereas the C2GnT and C3GnT knockout mice developed normally, but displayed increased susceptibility to experimental triggers of colitis and colorectal adenocarcinoma (An et al. 2007; Stone et al. 2009).”
BackgroundLijie, S., Shi, L., Leilei, L., Xiuxian, F., Wang, J., Qiang, Y., Shiwei, C., Jing, G., Fenglin, Z., & He, S.-F. (2017) · 中医杂志:英文版 · doi:10.1016/s0254-6272(17)30151-6 · Cited by 7
Polypeptide‑GalNAc‑T6 expression predicts better overall survival in patients with colon cancer
Ubillos, L., Berriel, E., Mazal, D., Victoria, S., Barrios, E., Osinaga, E., & Berois, N. (2018) · Oncology Letters · doi:10.3892/ol.2018.8686 · Cited by 12
“…enzyme for the synthesis of core 3-derived O -glycans, exhibited an increased susceptibility to experimental colitis and colorectal adenocarcinoma (23); v) in addition, it was found that inactivating somatic and germline mutations in the gene encoding for GalNAc-T12 ( GALNT12 ) (a gene highly…”
Fu, Q., Li, G., Wang, C., Wang, Y., Li, Q., Hao, J., & Yu, G. (2019) · Molecules · doi:10.3390/molecules24071365 · Cited by 7
“This structure has showed an important role in reducing intestinal permeability and levels of bacteria within mucosa, thus promoting mucosal barrier function [24].”
BackgroundKunkl, M., Amormino, C., Frascolla, S., Sambucci, M., Bardi, M. D., Caristi, S., Arcieri, S., Battistini, L., & Tuosto, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590964 · Cited by 9
“Similarly, a reduced glycosylation of MUC1 increased both susceptibility to colitis and progression to colon cancers (77, 78).”
BackgroundTechniques for Assessment of Interactions of Mucins with Microbes and Parasites In Vitro and In Vivo
Sheng, Y., Hasnain, S. Z., Png, C. W., McGuckin, M. A., & Lindén, S. K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-513-8_18 · Cited by 7
Targeting Glycosylation Aberrations to Improve the Efficiency of Cancer Phototherapy
Poiroux, G., Barre, A., Rougé, P., & Benoist, H. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180628101059 · Cited by 7
Pinho, S. S., Torres, J., & Colombel, J. F. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01164-7 · Cited by 8
Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
Li, Y., Li, D., Chen, Y., Lu, Y., Zhou, F., Li, C., Zeng, Z., Cai, W., Lin, L., Li, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.727752 · Cited by 6
STXBP6 and B3GNT6 Genes are Associated With Selective IgA Deficiency
Lim, C. K., Bronson, P. G., Varadé, J., Behrens, T. W., & Hammarström, L. L. G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.736235 · Cited by 7
“B3GNT6 has previously been reported to be associated with inflammatory colitis (An et al., 2007).”
BackgroundCarbohydrate composition of rat intestine surface mucus layer after ceftriaxone treatment
Голота, Ю. В., Olefir, Y. A., Dovbynchuk, T., & Tolstanova, G. M. (2016) · The Ukrainian Biochemical Journal · doi:10.15407/ubj88.06.035 · Cited by 6
Gut bacterial O -demethylation modulates systemic exposure to oral etoposide
Tripathi, A., Kyawt, T. E., Shin, J., Kyoung-Jae, W., Armstrong, A. T., Ilktach, G., Sullivan, P., Weilbaker, H. A., Ko, Y., Lee, S., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2628358 · Cited by 7
Core3 Glycan as Tumor Suppressor
Lee, S. H., & Fukuda, M. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)79008-x · Cited by 5
“Core3 structure was reported that it is very important cell surface glycan structure for gastric track disease such as colitis, and elimination of core3 structure on colon results in reduced expression of Muc2 protein with increased permeability of the intestinal barrier (An et al., 2007).”
BackgroundDall’Olio, F., Malagolini, N., & Chiricolo, M. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732765-00021 · Cited by 7
Manganese ion concentration affects production of human core 3 O-glycan in Saccharomyces cerevisiae
Saito, F., Sakamoto, I., Kanatani, A., & Chiba, Y. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.05.038 · Cited by 5
Zhang, F., Zhao, Y., Liu, X., Li, Z., Liu, N., Tang, L., Jiang, Q., Fan, Z., Tan, B., Li, Y., et al. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12858 · Cited by 4
Liu, Y., & Peng, F. (2021) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v13.i2.96 · Cited by 5
Khavani, M., Mehranfar, A., & Mofrad, M. R. K. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70091 · Cited by 4
Jankowski, W. M., Fichna, J., & Tarasiuk, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04181-0 · Cited by 3
“Core 3 O-glycans, synthesized by the enzyme glycosyltransferase β3GNT6, play a crucial role in maintaining the integrity of the intestinal barrier (An et al. 2007; Wu et al. 2018).”
Wang, X., Luo, Q., Yang, J., Peng, W., Dong, G., Hu, X., & Dai, W. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106863 · Cited by 4
Characterization of intestinal O-glycome in reactive oxygen species deficiency
Saldova, R., Thomsson, K. A., Wilkinson, H., Chatterjee, M., Singh, A. K., Karlsson, N. G., & Knaus, U. G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297292 · Cited by 4
Correlation of Tn antigen expression with mucins in Chinese patients with colorectal cancer.
Jiang, Y., Liu, Z., Hu, Y., Gao, T., Wen, T., & An, G. (2018) · PubMed Central · Cited by 3
Self-citationEthanol effects on mucin glycosylation: Another kick in the gut?
Valatas, V., & Kolios, G. C. (2009) · Annals of Gastroenterology · Cited by 5
Recent Progress in Carbohydrate Biosynthesis and Function in Relation to Tumor Biology
Fukuda, M. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00446 · Cited by 3
Understanding the Epithelial Barrier in Inflammatory Bowel Disease
Bradford, E. M., Turner, E. S., & Turner, J. R. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0998-4_4 · Cited by 3
The MUC2 mucin -A network in the intestinal protective mucus
Johansson, M. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 5
Complex Glycans and Immune Regulation
Paschall, A. V., Middleton, D. R., & Avci, F. Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00004-3 · Cited by 3
Tull, S. P., Saviano, A., Fatima, A., Begum, J., Mansour, A. A., Marigliano, N., Schettino, A., Blaising, J., Trenkle, P., Sandrin, V., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117902 · Cited by 4
“Aberrations to glycan interactions, can lead to altered mucosal immunity which is implicated in the pathogenesis of IBD [7 – 9].”
Weng, G., Ma, X., Yu, M., Song, M., Liu, Z., Deng, J., Yin, Y., & Deng, D. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70019 · Cited by 2
“32 De fi ciencies in Muc2 and glycans may result in a thinner mucus layer and predispose the host to pathogen infection and intestinal in fl ammation.”
Brocca, M. E., Mora-Rubio, A., Alonso‐Calviño, E., Fernández‐López, E., Díez‐Revuelta, N., Guirado, J. C., Álvarez, R., Dopazo, A., López-Merino, E., Martos-Puñal, D., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.006 · Cited by 2
Fuss, I. J., & Strober, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00081-1 · Cited by 3
Mucin-Type O-Glycans: Biosynthesis and Functions
Brockhausen, I., & Argüeso, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00033-x · Cited by 3
Sialic Acid-Binding Ig-Like Lectins (Siglecs)
Kim, C. (2022) · Springer eBooks · doi:10.1007/978-981-16-9081-5_7 · Cited by 3
O-Glycosylation and Development
Hagen, K. G. T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54841-6_64 · Cited by 2
The role of mucus in the cross talk between gut bacteria and the host
Kober, O. I. (2013) · UEA Digital Repository (University of East Anglia) · Cited by 4
Cancer-associated alterations in O-GalNAc glycosylation
Pires, J., Rochat, E., Bagdonaite, I., Dabelsteen, S., & Wandall, H. H. (2026) · Glycobiology · doi:10.1093/glycob/cwag049 · Cited by 1
“…O-glycans in the gastrointestinal tract compromises the mucus barrier and precipitates microbiota-dependent , inflammasome - linked pathologies that increase the risk of carcinomas ( An et al. 2007; Fu et al. 2011; Gao et al. 2016; Kudelka et al. 2016; Bergstrom et al. 2017; Liu et al. 2020).”
Allen, T. R. (2014) · Immunome Research · doi:10.4172/1745-7580.1000074 · Cited by 1
“Defects in the extracellular barrier formed by secreted mucin may also contribute [28].”
BackgroundKoch, S., Nusrat, A., & Parkos, C. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8256-7_13 · Cited by 2
O-Glycosylation and Development
Hagen, K. G. T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54836-2_64-1 · Cited by 1
Glycosylation in Health and Disease
Chapman, E., & Hanson, S. R. (2011) · Pan Stanford Publishing eBooks · doi:10.1201/b11409-11 · Cited by 1
Metadata
- Authors
- An, G., Wei, B., Xia, B., McDaniel, J. M., Ju, T., Cummings, R. D., Braun, J., & Xia, L.
- Affiliations
- Oklahoma Medical Research Foundation (US)
- University of California, Los Angeles (US)
- Emory University (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-05-21
- Volume
- 204
- Issue
- 6
- Pages
- 1417-1429
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118614
- OpenAlex
- W2047595952
- Cited by
- 352
- References
- 65
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 25 · 2021: 26 · 2020: 20 · 2019: 14 · 2018: 20 · 2017: 9 · 2016: 15 · 2015: 21 · 2014: 28 · 2013: 16 · 2012: 20
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL085607)
- National Cancer Institute (P30CA016042)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK069434, R01DK069434)
- National Center for Research Resources (RR 018758, P20RR018758)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- mucin core proteins, MUC2, intestinal mucus, intestinal permeability, colitis, colorectal adenocarcinoma, ulcerative colitis, colorectal cancer, knockout mice, glycosylation
- MeSH terms
- Animals, Colitis, Colon, Disease Susceptibility, Immunohistochemistry, Mucins, Polysaccharides, Immunoblotting, Colorectal Neoplasms, N-Acetylglucosaminyltransferases, DNA Primers, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Microscopy, Electron, Transmission, Mice, Mucin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.